170 related articles for article (PubMed ID: 27562495)
1. QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas.
Knutsvik G; Collett K; Arnes J; Akslen LA; Stefansson IM
Mod Pathol; 2016 Dec; 29(12):1485-1491. PubMed ID: 27562495
[TBL] [Abstract][Full Text] [Related]
2. Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer.
Katchman BA; Ocal IT; Cunliffe HE; Chang YH; Hostetter G; Watanabe A; LoBello J; Lake DF
Breast Cancer Res; 2013 Mar; 15(2):R28. PubMed ID: 23536962
[TBL] [Abstract][Full Text] [Related]
3. High expression of QSOX1 is associated with tumor invasiveness and high grades groups in prostate cancer.
Baek JA; Song PH; Ko Y; Gu MJ
Pathol Res Pract; 2018 Jul; 214(7):964-967. PubMed ID: 29804717
[TBL] [Abstract][Full Text] [Related]
4. Illuminating luminal B: QSOX1 as a subtype-specific biomarker.
Das P; Siegers GM; Postovit LM
Breast Cancer Res; 2013 May; 15(3):104. PubMed ID: 23680167
[TBL] [Abstract][Full Text] [Related]
5. High expression of QSOX1 reduces tumorogenesis, and is associated with a better outcome for breast cancer patients.
Pernodet N; Hermetet F; Adami P; Vejux A; Descotes F; Borg C; Adams M; Pallandre JR; Viennet G; Esnard F; Jouvenot M; Despouy G
Breast Cancer Res; 2012 Oct; 14(5):R136. PubMed ID: 23098186
[TBL] [Abstract][Full Text] [Related]
6. Elevated transcription of the gene QSOX1 encoding quiescin Q6 sulfhydryl oxidase 1 in breast cancer.
Soloviev M; Esteves MP; Amiri F; Crompton MR; Rider CC
PLoS One; 2013; 8(2):e57327. PubMed ID: 23460839
[TBL] [Abstract][Full Text] [Related]
7. The emerging role of QSOX1 in cancer.
Lake DF; Faigel DO
Antioxid Redox Signal; 2014 Jul; 21(3):485-96. PubMed ID: 24359107
[TBL] [Abstract][Full Text] [Related]
8. Expression level of quiescin sulfhydryl oxidase 1 (QSOX1) in neuroblastomas.
Araújo DG; Nakao L; Gozzo P; Souza CD; Balderrama V; Gugelmin ES; Kuczynski AP; Olandoski M; de Noronha L
Eur J Histochem; 2014 Mar; 58(1):2228. PubMed ID: 24704990
[TBL] [Abstract][Full Text] [Related]
9. QSOX1 inhibits autophagic flux in breast cancer cells.
Poillet L; Pernodet N; Boyer-Guittaut M; Adami P; Borg C; Jouvenot M; Delage-Mourroux R; Despouy G
PLoS One; 2014; 9(1):e86641. PubMed ID: 24475161
[TBL] [Abstract][Full Text] [Related]
10. Quiescin Sulfhydryl Oxidase 1 (QSOX1) Secreted by Lung Cancer Cells Promotes Cancer Metastasis.
Sung HJ; Ahn JM; Yoon YH; Na SS; Choi YJ; Kim YI; Lee SY; Lee EB; Cho S; Cho JY
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30336636
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated macrophages are strongly related to vascular invasion, non-luminal subtypes, and interval breast cancer.
Klingen TA; Chen Y; Aas H; Wik E; Akslen LA
Hum Pathol; 2017 Nov; 69():72-80. PubMed ID: 28923419
[TBL] [Abstract][Full Text] [Related]
12. Molecular Inhibitor of QSOX1 Suppresses Tumor Growth
Fifield AL; Hanavan PD; Faigel DO; Sergienko E; Bobkov A; Meurice N; Petit JL; Polito A; Caulfield TR; Castle EP; Copland JA; Mukhopadhyay D; Pal K; Dutta SK; Luo H; Ho TH; Lake DF
Mol Cancer Ther; 2020 Jan; 19(1):112-122. PubMed ID: 31575656
[TBL] [Abstract][Full Text] [Related]
13. Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survival.
Klingen TA; Chen Y; Stefansson IM; Knutsvik G; Collett K; Abrahamsen AL; Aase H; Aas H; Aas T; Wik E; Akslen LA
J Clin Pathol; 2017 Apr; 70(4):313-319. PubMed ID: 27612505
[TBL] [Abstract][Full Text] [Related]
14. Quiescin sulfhydryl oxidase 1 promotes invasion of pancreatic tumor cells mediated by matrix metalloproteinases.
Katchman BA; Antwi K; Hostetter G; Demeure MJ; Watanabe A; Decker GA; Miller LJ; Von Hoff DD; Lake DF
Mol Cancer Res; 2011 Dec; 9(12):1621-31. PubMed ID: 21989104
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
[TBL] [Abstract][Full Text] [Related]
16. Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade.
Makretsov NA; Hayes M; Carter BA; Dabiri S; Gilks CB; Huntsman DG
Mod Pathol; 2007 Jan; 20(1):84-9. PubMed ID: 17143263
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer.
Bauer M; Eickhoff JC; Gould MN; Mundhenke C; Maass N; Friedl A
Breast Cancer Res Treat; 2008 Apr; 108(3):389-97. PubMed ID: 17554627
[TBL] [Abstract][Full Text] [Related]
18. An inhibitory antibody blocks the first step in the dithiol/disulfide relay mechanism of the enzyme QSOX1.
Grossman I; Alon A; Ilani T; Fass D
J Mol Biol; 2013 Nov; 425(22):4366-78. PubMed ID: 23867277
[TBL] [Abstract][Full Text] [Related]
19. Histone demethylase GASC1--a potential prognostic and predictive marker in invasive breast cancer.
Berdel B; Nieminen K; Soini Y; Tengström M; Malinen M; Kosma VM; Palvimo JJ; Mannermaa A
BMC Cancer; 2012 Nov; 12():516. PubMed ID: 23148692
[TBL] [Abstract][Full Text] [Related]
20. In modern times, how important are breast cancer stage, grade and receptor subtype for survival: a population-based cohort study.
Johansson ALV; Trewin CB; Fredriksson I; Reinertsen KV; Russnes H; Ursin G
Breast Cancer Res; 2021 Feb; 23(1):17. PubMed ID: 33526044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
